Mayo Clinic is one of six new federally-funded Comprehensive Metabolomics (met-ah-bol-OH-mics) Centers to support medical research on metabolomics — the study, at the cellular level, of how molecules are metabolized in the body. Understanding these molecular mechanisms is proving increasingly important in the understanding, diagnosis and treatment of many diseases, including virtually every form of cancer.
The award from the National Institutes of Health (NIH) is for $8.8 million over five years. “It is certainly an honor to be selected as one of the six national centers which will serve as resources for universities and other research institutions. This offers a tremendous opportunity for Mayo Clinic to be a national leader in this emerging research area,” says K. Sreekumaran Nair, M.D., Ph.D., Mayo Clinic endocrinologist and principal investigator on the grant, as well as head of Mayo’s Comprehensive Metabolomics Core facility.
To read the full news release click here.